Effects of various priming solutions upon extra- and intra-cellular water and electrolytes following the hemodilution technique of extracorporeal circulation. An new priming solution "LMDAS".
D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D001826:Body Fluids / Q000032:analysis*; D003102:Colloids; D003911:Dextrans / Q000494:pharmacology*; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004285:Dogs; D005110:Extracellular Space / Q000032:analysis; D005112:Extracorporeal Circulation; D006331:Heart Diseases / Q000188:drug therapy; D006344:Heart Septal Defects, Atrial / Q000378:metabolism*; D006439:Hemodynamics; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007201:Indicator Dilution Techniques; D008944:Mitral Valve Insufficiency / Q000378:metabolism; D008946:Mitral Valve Stenosis / Q000378:metabolism; D009132:Muscles / Q000032:analysis; D009995:Osmosis; D010477:Perfusion; D011188:Potassium / Q000032:analysis; D012964:Sodium / Q000032:analysis; D012965:Sodium Chloride / Q000032:analysis; D014882:Water-Electrolyte Balance
D000596:Amino Acids; D003102:Colloids; D003911:Dextrans; D004071:Digitalis Glycosides; D012965:Sodium Chloride; D012964:Sodium; D011188:Potassium